Image
After years of back and forth, the U.S. Food and Drug Administration (FDA) approved a clinical trial to determine whether cannabis helps veterans with post-traumatic stress disorder (PTSD). This critical multi-state study, dubbed MJP2, will include more than 300 participants. The researchers argue